Considering that PTEN loss-of-function causes PHTS and promotes cancer progression in tumors such as glioblastoma, with insufficient therapeutic armamentarium, it is necessary to delve into testing the potential of PTEN modifications as targets for PTEN reactivation. The gene discussed is PTEN; the disease is PTEN hamartoma tumor syndrome.